Sihuan Pharm buys back 10.00 million shares; issued share base trimmed by 0.11%

Bulletin Express05-18

Sihuan Pharmaceutical Holdings Group Ltd. disclosed a next-day return confirming the repurchase of 10.00 million ordinary shares on 18 May 2026. The on-exchange purchases were executed at prices between HKD 1.05 and HKD 1.08, translating to a volume-weighted average cost of HKD 1.0685 per share and a total cash outlay of HKD 10.69 million.

Following the transaction, the company’s issued shares (excluding treasury shares) declined 0.11% to 9.13 billion, while treasury shares increased to 204.01 million. Total outstanding shares remain unchanged at 9.33 billion.

The buyback forms part of a mandate approved on 6 June 2025 that authorises the repurchase of up to 921.36 million shares. Cumulative repurchases under this mandate now stand at 87.60 million shares, representing 0.95% of the issued share count at the time the mandate was granted.

In accordance with Hong Kong listing rules, Sihuan Pharm is subject to a moratorium on issuing new shares or disposing of treasury shares until 17 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1151261369?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-18 18:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151261369","market":"hk","top_or_hot":-1,"title":"Sihuan Pharm buys back 10.00 million shares; issued share base trimmed by 0.11%","media":"Bulletin Express","content":"<p>Sihuan Pharmaceutical Holdings Group Ltd. disclosed a next-day return confirming the repurchase of 10.00 million ordinary shares on 18 May 2026. The on-exchange purchases were executed at prices between HKD 1.05 and HKD 1.08, translating to a volume-weighted average cost of HKD 1.0685 per share and a total cash outlay of HKD 10.69 million.</p>\n<p>Following the transaction, the company’s issued shares (excluding treasury shares) declined 0.11% to 9.13 billion, while treasury shares increased to 204.01 million. Total outstanding shares remain unchanged at 9.33 billion.</p>\n<p>The buyback forms part of a mandate approved on 6 June 2025 that authorises the repurchase of up to 921.36 million shares. Cumulative repurchases under this mandate now stand at 87.60 million shares, representing 0.95% of the issued share count at the time the mandate was granted.</p>\n<p>In accordance with Hong Kong listing rules, Sihuan Pharm is subject to a moratorium on issuing new shares or disposing of treasury shares until 17 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sihuan Pharm buys back 10.00 million shares; issued share base trimmed by 0.11%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSihuan Pharm buys back 10.00 million shares; issued share base trimmed by 0.11%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-18 18:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sihuan Pharmaceutical Holdings Group Ltd. disclosed a next-day return confirming the repurchase of 10.00 million ordinary shares on 18 May 2026. The on-exchange purchases were executed at prices between HKD 1.05 and HKD 1.08, translating to a volume-weighted average cost of HKD 1.0685 per share and a total cash outlay of HKD 10.69 million.</p>\n<p>Following the transaction, the company’s issued shares (excluding treasury shares) declined 0.11% to 9.13 billion, while treasury shares increased to 204.01 million. Total outstanding shares remain unchanged at 9.33 billion.</p>\n<p>The buyback forms part of a mandate approved on 6 June 2025 that authorises the repurchase of up to 921.36 million shares. Cumulative repurchases under this mandate now stand at 87.60 million shares, representing 0.95% of the issued share count at the time the mandate was granted.</p>\n<p>In accordance with Hong Kong listing rules, Sihuan Pharm is subject to a moratorium on issuing new shares or disposing of treasury shares until 17 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00460","symbol_name":"四环医药","start_time":0,"source_url":"","article_id":"1151261369","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151261369","pubTimestamp":1779098651,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sihuan Pharmaceutical Holdings Group Ltd. disclosed a next-day return confirming the repurchase of 10.00 million ordinary shares on 18 May 2026. The on-exchange purchases were executed at prices...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00460":"四环医药"},"translate_title":"四环医药回购1000万股；已发行股本削减0.11%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00460":1},"content_text":"Sihuan Pharmaceutical Holdings Group Ltd. disclosed a next-day return confirming the repurchase of 10.00 million ordinary shares on 18 May 2026. The on-exchange purchases were executed at prices between HKD 1.05 and HKD 1.08, translating to a volume-weighted average cost of HKD 1.0685 per share and a total cash outlay of HKD 10.69 million.\nFollowing the transaction, the company’s issued shares (excluding treasury shares) declined 0.11% to 9.13 billion, while treasury shares increased to 204.01 million. Total outstanding shares remain unchanged at 9.33 billion.\nThe buyback forms part of a mandate approved on 6 June 2025 that authorises the repurchase of up to 921.36 million shares. Cumulative repurchases under this mandate now stand at 87.60 million shares, representing 0.95% of the issued share count at the time the mandate was granted.\nIn accordance with Hong Kong listing rules, Sihuan Pharm is subject to a moratorium on issuing new shares or disposing of treasury shares until 17 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.4","shortVersion":"4.42.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1151261369","isCrawlerRequest":true}